Trademark Overview
On Tuesday, April 12, 2016, a trademark application was filed for POZENTIA with the United States Patent and Trademark Office. The USPTO has given the POZENTIA trademark a serial number of 86972425. The federal status of this trademark filing is ABANDONED - EXPRESS as of Tuesday, July 19, 2016. This trademark is owned by Purdue Pharma. The POZENTIA trademark is filed in the Pharmaceutical Products category with the following description:
pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders, mood disorders, oppositional defiance disorder, conduct disorder, learning disabilities, autism spectrum disorder, tic disorders, binge eating and obsessive eating disorders, anxiety disorders, substance abuse disorders, depression, psychosis